- Updated:
- Country/Territory:
- Headquarters:Summit, N.J.
- Industry:Pharmaceuticals
- CEO:Mark J. Alles
- Website:https://www.celgene.com
- Ticker:CELG
- Company type:
- Revenues ($M):$15,281
- Profits ($M):$4,046
- Market value ($M):$66,242
- Number of employees:8,852
Celgene
- Company Information
- Key Financials (last Fiscal Year)
- Profit Ratios
- Earnings Per Share (last Fiscal Year)
- Total Return
- Future 50
- $ millions% change
- Revenues ($M):$15,28117.5%
- Profits ($M):$4,04637.6%
- Assets ($M):$35,480-
- Total Stockholder Equity ($M):$6,161-
- Profit as % of Revenues:26.5%
- Profits as % of Assets:11.4%
- Profits as % of Stockholder Equity:65.7%
- Earnings Per Share ($):5.51
- EPS % Change (from prior fiscal year):51.4%
- EPS % Change (5 year annual rate):26.7%
- Total Return to Investors (last year):-38.6%
- Total Return to Investors (5 year, annualized):-5.4%
- Total Return to Investors (10 year, annualized):8.8%
- Overall Score:1.7
- Sector:Health Care
- Industry:Pharmaceuticals
- CEO:Mark J. Alles
- Website:https://www.celgene.com
- Employees:7,132
- HQ Location:Summit, N.J.
- Revenues ($M) (Past 12 Months):$12,191
- Profits ($M) (Past 12 Months):$2,602
- Market Value as of Oct. 9, 2019 ($M):$108,958
Celgene stock chart
Celgene in Fortune Rankings
- Fortune 500
- The Future 50